Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down after eight years at the helm, as the Danish pharmaceutical giant ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...

May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...

The papers are dominated by better deals expected with the EU and Sir Keir Starmer's pivot on winter fuel payments.

The latest attempt focuses on liraglutide, an older, once-daily injectable product in Novo Nordisk's GLP-1 agonist franchise sold as Victoza and Xultophy for diabetes and Saxenda for obesity.

so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living with diabetes, obesity, and growth disorders is a welcome step forward. The new PenCycle programme ...

Novo Nordisk announced the resignation of CEO Lars Fruergaard Jorgensen amid escalating pressures in the obesity drug market. Analysts have speculated that the company's struggle to maintain its ...